Search Results

Search Results (1754)

Mark Elliott

Mark Elliott is the Chairman & CEO of Opportunity South Carolina with over 15 years of real estate investment experience. Focusing on Opportunity Zones, he is working with developers, investors, municipalities, other funds and property owners. Mark has done a range of deals from single-family homes to large mixed-use developments…

Site Section: Members/Directors/Staff

Armin Spura

Dr. Armin Spura joined BioDuro in 2024 from Crown Bioscience, where he served as the Chief Executive Officer (CEO) for nearly five years, guiding the company through significant growth and strategic development. Throughout his career, Armin has held senior leadership positions at well-known organizations such as Thermo Fisher Scientific, WuXi…

Site Section: Members/Directors/Staff

Darren Nyberg

Darren Nyberg is the Vice President of Client Strategy at Xantrion. With 17 years of experience helping small and medium businesses navigate the rapidly evolving IT landscape, Darren now leads the strategic advisor team at Xantrion. Throughout his 14-year tenure at Xantrion, Darren has held various positions, including Help Desk…

Site Section: Members/Directors/Staff

Axiom Cloud Raises $7.4M Series A

SAN JOSE, Calif.—Axiom Cloud announced its $7.4M Series A financing led by Blue Bear Capital. Following large-scale rollouts with major North American grocery chains and cold storage warehouse operators, Axiom raised its Series A to prepare for its next phase of growth. Axiom will use the funding to scale its…

Read More

Site Section: News

Alliance Roundtable

Our September 27/28 Alliance Keystone Leadership Roundtable brought CEOs together from 12 different countries and 6 continents to reflect on the wonderous “learning lab” of nature, the impact Keystone leaders have on others, and the tracks they leave for others to follow. You can find resources from this discussion here.

Read More

Site Section: Public Events

Matthew Swanson

Matthew Swanson founded StaffAI in 2026 and serves as the company’s CEO. Matthew is also the managing partner for Silicon Valley Software Group (SVSG), a team of fractional CTOs who help companies address their most pressing technology challenges. Having launched multiple enterprise focused startups, he has had first-hand experience helping…

Site Section: Members/Directors/Staff

Jay Roberts

Jay Roberts has been a senior strategic executive in the healthcare industry for over 30 years. He is currently the Managing Partner for DigiLife Fund II, leading fundraising, due diligence and investment decisions along with members of the DigiLife team and syndicate investment funds. He currently serves as a member…

Site Section: Members/Directors/Staff

6 Alliance Members Make the INC 5000 Fastest Growing List

Congratulations to the following Alliance Members whose companies were named to the 2022 INC 5000 list of the fastest growing companies in America. Folio3, led by CEO Adnan Lawai Innowave Marketing Group, led by CEO Stu Birger Jade Global, led by CEO Karan Yaramada Sama, led by CEO Wendy Gonzalez…

Read More

Site Section: News

Member Jessica Yuen Speaks: Onboarding a New CFO? Here’s How to Help Set Them – And Everyone Else – Up for Success

The Challenge: In the situation at hand, an executive hired a new CFO in the face of an evolving financial landscape. He was seeking insight into helping her adjust to the company culture, as well as guiding the organization to embrace a fiscally tighter path forward. If you were in…

Read More

Site Section: Member Insights

Alliance Visionary Leaders Roundtable

A recording of the “Future of Transportation & Mobility” Alliance Roundtable can be accessed by clicking HERE. The “Future of Transportation & Mobility” Alliance Roundtable was the fourth of our “Visionary Leaders” Series where we bring leaders together to share their visions, and debate how the future will evolve. Prior…

Read More

Site Section: Public Events

UNITY Biotechnology Announces Positive Data In Phase 2 BEHOLD Study

SOUTH SAN FRANCISCO, Calif. (GLOBE NEWSWIRE)— UNITY Biotechnology, Inc. (“UNITY”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced 12- and 18-week data from its Phase 2 BEHOLD study of UBX1325, a senolytic Bcl-xL inhibitor, in patients with diabetic macular edema (DME).…

Read More

Site Section: News

Tobias Sternbeck

Tobias Sternbeck was named Chief Executive Officer of Beaver Paper, a leading producer of sublimation media for the dye-sub and digital printing industry, in 2020. Tobias has over 15 years of experience delivering solutions for the sublimation and textile industries, along with expert knowledge of dye-sublimation, direct to fabric printing…

Site Section: Members/Directors/Staff

LOKKER Announces Launch of Privacy Edge

REDWOOD CITY, CA / ACCESSWIRE LOKKER, the Silicon Valley-based privacy software start-up, announced the launch of Privacy Edge™, a breakthrough SaaS solution for public-facing websites. In an industry rapidly evolving to meet the growing demands for a safer Internet, LOKKER offers Privacy Edge™ for companies seeking to better protect their…

Read More

Site Section: News

Karl Justin

Karl Justin is the principal partner of ECS Arizona, a company specializing in commissioning and programming new lighting and lighting control technologies. He has more than 30 years’ experience in implementing energy efficiency strategies in residential, commercial and industrial buildings, and now focuses on upgrading lighting technologies in existing buildings.…

Site Section: Members/Directors/Staff

Advent One Acquires Layer 8 Networks

Melbourne-based consultancy Advent One has acquired networks and IP telephony specialist and CRN Fast50 company Layer 8 Networks for an undisclosed sum. In its announcement, Advent One said the acquisition “comes at a time of surging demand” in hybrid cloud, network virtualisation and network security. Founded in 2017, Layer 8…

Read More

Site Section: News

Member Fred Canney Speaks: Steps for Prioritizing Profitability Over Growth

The Challenge: In the situation at hand, an executive of a public company had been prioritizing a fast-growth trajectory, but their value in the market wasn’t matching his competitors and he felt a lack of strong profitability may be the culprit. He was seeking insight into how to effectively balance…

Read More

Site Section: Member Insights

Protein Metrics receives Several US Patents

Protein Metrics Inc., a leading provider of biopharmaceutical and proteomics analysis software and part of the Dotmatics family of scientific R&D software, announced the granting of three new US patents. The patent names and numbers are entitled: “Interactive analysis of mass spectrometry data (US #11,289,317)”, “Data compression for multidimensional time…

Read More

Site Section: News

Loretta Hillberry

Loretta Hillberry brings over 20 years’ experience in human resources to Triple Ring Technologies. She is a forward-thinking, collaborative, and results-driven leader. Her experience ranges from pre-IPO start-up environments to larger global public companies. Most recently Loretta was a member of the leadership team at Freeslate (acquired by Unchained Labs).…

Site Section: Members/Directors/Staff

Legence Introduces New Brand and Announces Two Acquisitions

SAN JOSE, Calif., (GLOBE NEWSWIRE)— Legence (formerly Therma Holdings, LLC.) has assembled and integrated an experienced legion of best-in-class companies committed to making the spaces we occupy more sustainable. It has recently introduced a new brand and announced agreements for two new acquisitions – Provident Energy Consulting and McCracken &…

Read More

Site Section: News

Proxime Raises $80 Million in Series C Funding

LONDON, /PRNewswire/—Proximie, the global health technology platform digitally connecting operating rooms (OR) announces it has successfully raised $80 million in a Series C equity financing. The investment follows a year in which Proximie saw a significant increase in its Total Contracted Value, supported over 13,000 surgeries, and expanded their global…

Read More

Site Section: News

James Jackson

With more than 30 years in healthcare administration, James Jackson serves as the Chief Executive Officer of the Alameda Health System in Alameda County, California. Prior to this role, James was the Chief Operating Officer of Seton Medical Center & Seton Coastside, part of the Verity Healthcare System. James has…

Site Section: Members/Directors/Staff

54gene Signs MOU with Senegal’s National Academy of Sciences and Technology

54gene, the health technology company advancing African genomics research for improved global health outcomes, has partnered on a new Senegal research study SEN-GENOME, which will establish a full genomic database of the Senegalese population. Under the purview of the Ministry of Higher Education and Innovation of Senegal, a Memorandum of…

Read More

Site Section: News

Joseph Berger

Before becoming CEO of Pacific Epoch in 2014, Joseph Berger was Managing Director at Pacific Crest Securities in Portland, Oregon, with responsibility for overseeing research services such as Pacific Crest Mosaic and Pacific Epoch. He has 15+ years of investment research experience and has led product and sales teams for…

Site Section: Members/Directors/Staff

Oculi Wins Audience Choice Award at the Vision Tank Startup Competition

SANTA CLARA, Calif., /PRNewswire/—The Edge AI and Vision Alliance announced the winners of the 2022 Vision Tank competition at the Embedded Vision Summit. The annual start-up competition, which showcases the best new ventures using visual AI and computer vision in their products, invited five finalist companies to pitch their company…

Read More

Site Section: News

StockX Hires Damien Hooper-Campbell as Its First Chief Impact Officer

StockX has expanded its executive leadership team, tapping a tech industry veteran as its first-ever chief impact officer. The company announced today it has appointed Damien Hooper-Campbell for the role. In the position, StockX said Hooper-Campbell will be tasked with overseeing core functional areas including diversity, equity and inclusion, as…

Read More

Site Section: News

Brightseed’s First AI-Detected ‘Phytonutrient’ Comes to Market Alongside a $68M B Round

Who knows what secrets await in the hearts of plants? Brightseed has found a couple of them, anyway, using an AI-based analysis method and will be bringing its first products to market soon with the help of a $68 million B round. Brightseed’s thesis is simply that there are almost…

Read More

Site Section: News

5 Alliance Member Companies on the List of the Best Places to Work in the Bay Area

Congratulations to the following Alliance Members whose companies were named to this year's list of the “Best Places to Work in the Bay Area!” Legence, led by CEO Jeff Sprau Syserco, led by CEO Derek Eggers Webcor, led by President & CEO Jes Pedersen and Matt Rossie COO Xantrion, led…

Read More

Site Section: News

Pliant Therapeutics Receives FDA Fast Track Designation for the Treatment of Idiopathic Pulmonary Fibrosis

SOUTH SAN FRANCISCO, Calif. (GLOBE NEWSWIRE)—Pliant Therapeutics (NASDAQ: PLRX) announced that PLN-74809, its oral, dual-selective αvß6/αvß1 integrin inhibitor, has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for the potential treatment of idiopathic pulmonary fibrosis (IPF). PLN-74809, the Company’s lead drug candidate, is currently being tested…

Read More

Site Section: News

Universal Technical Institute to Acquire Concorde Career Colleges

PHOENIX /PRNewswire/—Universal Technical Institute, Inc. (NYSE: UTI), a leading provider of transportation and technical training programs, has entered into a definitive agreement to acquire Concorde Career Colleges, Inc. from Liberty Partners LLC. Terms of the transaction have been disclosed in Universal Technical Institute's Form 8-K and completion of the acquisition…

Read More

Site Section: News

Ashvattha Therapeutics Announces $69 Million in Series B Financing

REDWOOD CITY, Calif. – Ashvattha Therapeutics (“Ashvattha”), a clinical stage company developing novel hydroxyl dendrimer therapeutics, announced it has secured $69 million in a Series B financing and in a separate agreement entered an exclusive licensing deal with Huadong Medicine. Proceeds will support the advancement of Ashvattha’s pipeline of hydroxyl…

Read More

Site Section: News